If so, consider joining this study. UAB Researchers are studying immune responses in participants receiving a new investigational HIV vaccine. This study is open to HIV-negative adults aged 18 to 50 who are, generally, in good health. Participation in this study will last just under 3 years with 24 visits to the clinic. You CANNOT get HIV by participating in this clinical research trial. Compensation is provided after enrollment for those who qualify. For more information or to determine if you are eligible to participate, please call 205-996-4099 or visit www.uab.edu/avrc.
If you are ages 18-50, HIV-negative and in general good health, you may qualify to participate in an investigational HIV vaccine study comparing immune responses in two different vaccine regimens. You CANNOT get HIV by receiving the vaccine. Compensation is provided after enrollment for eligible participants. For more information, or to see if you qualify, please call 205-996-4099.
Healthy men and women aged 18-50 who are HIV negative are needed for an investigational HIV vaccine study. You cannot get HIV by receiving the vaccine. Compensation is provided after enrollment for all eligible participants. For more information, or to see if you qualify, please call 205-996-4099.
Recent studies have shown that a new vaginal ring containing a drug called Dapivirine is effective in protecting against HIV infection. A new study at UAB is looking at comparing this vaginal ring to two others, containing the same drug at higher doses. The study involves 10 clinic visits over a period of about 3 months. During this time, you will be randomly assigned to 1 of 3 treatment groups and will be asked to wear a vaginal ring for a period of about 3 months. In order to participate, you must be on birth control for the entire duration of the study. If enrolled, you will receive physical/GYN exams and HIV/STI testing at no cost and will be compensated up to $975 for your time. For more information, call the study team at (205) 996-4405.
If you are a man or transgender woman who has sex with men, are at least 18 years of age, and in general good health, you may qualify to participate in a clinical research study evaluating an investigational medication as PrEP for HIV prevention. You CANNOT get HIV by participating in this study. Compensation is provided after enrollment for all eligible participants. For more information, or to see if you qualify, please call 205-934-6777.
If you are a man or transgender woman who has sex with men, ages 18 and older, and in general good health, you may qualify to participate in a clinical research study evaluating an investigational medication as PrEP for HIV prevention. You CANNOT get HIV by participating in this study. Compensation is provided after enrollment for all eligible participants. For more information, or to see if you qualify, please call 205-934-6777.